Madeline Li, MD, PhD
- 2Articles
- 34.6KReads
- 2019–2020Active
- 5Collaborators
- 100Citations
About
Madeline Li, MD, PhD, has published research focused on the use of oral ketamine for the treatment of major depressive disorder (MDD). Her work includes a systematic review and a correction related to this topic, appearing between 2019 and 2020 in Psychiatrist.com. She has frequently collaborated with co-authors such as Andre F. Carvalho, Joshua D. Rosenblat, Mehala Subramanieapillai, Roger S. McIntyre, and Yena Lee.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
